Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01864954 · ClinicalTrials.gov registry record · NA

Web and Phone Intervention to Maintain Postpartum Tobacco Abstinence

A NA study, sponsored by Oregon Research Institute.

Completed
Registry status
NA
Development phase
62
Enrollment target

NCT01864954: Completed NA study, sponsored by Oregon Research Institute.

NCT01864954 is a NA study that has completed, run by Oregon Research Institute. The registered enrollment target is 62 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01864954, a NA study, has completed, sponsored by Oregon Research Institute.

COMPLETED
Registry status
NA
Development phase
62 participants
Enrollment target

Study Summary

This study seeks to develop and test a Web-based tobacco relapse prevention program targeting postpartum women who quit smoking for pregnancy. Participants are randomly assigned to one of two conditions: (1) an Enhanced Web+phone Condition that receives access to an interactive Web-based intervention plus up to 3 brief supportive phone calls from a personal coach; (2) A Basic Web Information-Only Control Condition that receives access to an informational website plus an introductory phone call. The hypothesis is that Women in the Enhanced Condition will be more successful in avoiding tobacco relapse than women assigned to the Basic Control Condition.

Primary Outcome

Measure change in 7-day point all tobacco abstinence and change in prolonged abstinence between 3 and 6 months postpartum.

Interventions

  • BEHAVIORAL Web+phone

Trial Details

FieldValue
Enrollment Target 62 participants
Start Date 2013-12
Est. Completion 2015-05
Phase NA
Oregon Research Institute

62 total trials

What the finished NCT01864954 record still lists

NCT01864954 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 62 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).

The record links to 0 conditions, and to 1 intervention - of which Web+phone is the first listed.

NCT01864954 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01864954 about?

NCT01864954 is a clinical study titled "Web and Phone Intervention to Maintain Postpartum Tobacco Abstinence". This study seeks to develop and test a Web-based tobacco relapse prevention program targeting postpartum women who quit smoking for pregnancy. Participants are randomly assigned to one of two conditions: (1) an Enhanced Web+phone Condition that receives access to an interactive Web-based interventio...

What is the current status of trial NCT01864954?

This trial is currently completed. It is a NA study. The enrollment target is 62 participants. The study started on 2013-12. Estimated completion is 2015-05.

What interventions are being tested in trial NCT01864954?

The interventions under investigation include: Web+phone (BEHAVIORAL).

Who is sponsoring clinical trial NCT01864954?

This trial is sponsored by Oregon Research Institute, which has 62 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01864954's enrollment target sits among peer trials

62 1157th of 2000 higher than 837 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03231150 · 62 participants · NA

    Plantar Fasciitis Randomized Clinical Control Trial

  • NCT03458676 · 62 participants · NA

    Radiologic Pathologic Correlation of Advanced MR Imaging to Guide the Biopsy of Cerebral Malignancies

  • NCT03596086 · 62 participants · Phase 1

    HSV-tk + Valacyclovir + SBRT + Chemotherapy for Recurrent GBM

  • NCT03603405 · 62 participants · Phase 1

    HSV-tk and XRT and Chemotherapy for Newly Diagnosed GBM

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01864954, the US trial registry maintained by the National Library of Medicine. NCT01864954 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.